At SkinnyRx, we focus on making GLP-1 care more accessible by offering doctor-guided options for semaglutide and tirzepatide that are both clinically appropriate and cost-conscious
Allocation decisions can become ethically and operationally sensitive , particularly when patients with chronic glycemic needs compete with new initiations for weight management
In UK clinical practice, co-prescribing a GLP-1 receptor agonist (like Rybelsus) with a DPP-4 inhibitor (like Januvia) is generally not recommended
The fact of the matter is that I just think women deserve good care, accurate information, and products that have been appropriately researched
If you are navigating GLP-1 treatment alongside an eating disorder history, an active eating disorder, or simply a complicated relationship with food and your body, you deserve care that sees the full picture